Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

235.67 +2.66 (+1.14%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Got $5,000? These 3 Stocks Are Ridiculously Cheap Buys ↗

June 29, 2021

They are great options whether you are investing for the short or long term.

Via The Motley Fool

Topics Cannabis

Finding Value In Mid-Cap Stocks ↗

June 24, 2021

Within the mid-cap space there is something for everyone.

Via Talk Markets

New Cannabinoid-Based Drug Candidates from Artelo Biosciences Show Promise as Cancer and Mental Health Treatments; Key Data Due Before Year End ↗

June 24, 2021

The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in no way represents investment advice or...

Via Benzinga

14 Biotech Stocks To Watch Over The Next 6 Months ↗

June 23, 2021

Biotechs are at the mercy of several make-or-break catalysts that invariably have a big impact on stocks. A case in point was the strong upside in Biogen Inc.'s (NASDAQ:...

Via Benzinga

Where Jazz Pharmaceuticals Stands With Analysts ↗

June 22, 2021

Within the last quarter, Jazz Pharmaceuticals (NASDAQ:JAZZ...

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

June 22, 2021

Goldman Sachs lowered Casey's General Stores, Inc. (NASDAQ:

Via Benzinga

10 Health Care Stocks Showing Unusual Options Activity In Today's Session ↗

June 21, 2021

This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

June 21, 2021

SVB Leerink raised Natera, Inc. (NASDAQ:NTRA) pr...

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

June 18, 2021

Piper Sandler raised Adobe Inc. (NASDAQ: ADBE) price target from $570 to $600. Adobe shares rose 3.3% to $569.50 in pre-market trading. SVB Leerink boosted Jazz...

Via Benzinga

Jazz Pharmaceuticals Updates 2021 Guidance To Include GW Pharma Acquisition ↗

June 17, 2021

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has updated its full-year 2021 financial guidance to incorporate the GW Pharmaceuticals business, which the company...

Via Benzinga

The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO ↗

June 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts ↗

June 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda ↗

June 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal ↗

June 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 9) Aethlon Medical, Inc. (...

Via Benzinga

Cannabis investors Discuss Strategies For 2021 In The Context Of Consolidation And Interstate Commerce ↗

June 09, 2021

2021 seems to be the year of cannabis, as its prospects and apparent societal acceptance have dramatically changed since the industr...

Via Benzinga

Topics Cannabis

Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels

June 08, 2021

Via FinancialNewsMedia

Topics Cannabis Economy

6 Mid-Cap Gems for Growth at a Reasonable Price ↗

June 04, 2021

A look at 6 attractively valued mid-cap stocks that are trading at valuations that are lower than their expected long-term growth rates.

Via Talk Markets

Agentix Corp. (AGTX) Signs Deal With NHRI To License CBD-Based Compound To Treat Type 2 Diabetes; Adds Catalyst To Back Half Of 2021

June 02, 2021

Via AB Newswire

Topics Intellectual Property

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal ↗

May 25, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company...

Via Benzinga

This Could Be The Most Exciting Healthcare Development Of The Year

May 21, 2021

Via FinancialNewsMedia

Topics Artificial Intelligence Cannabis

Medical Stocks Jazz, Horizon Are Accelerating But Iqvia Is Hitting The Brakes ↗

May 17, 2021

Jazz Pharmaceuticals and Horizon Therapeutics are among a cadre of accelerating medical stocks, while big names like Iqvia Holdings are hitting the brakes.

Via Investor's Business Daily

10 Biggest Price Target Changes For Monday ↗

May 17, 2021

Morgan Stanley boosted the price target on Applied Materials, Inc. (NASDAQ: AMAT) from $113 to $137. Applied Materials shares fell 1.1% to $123.46 in pre-market trading....

Via Benzinga

Cramer Advises Viewers On Suncor, Jazz And More ↗

May 14, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said that in the energy space he is recommending only Chevron Corporation (NYSE: CVX) and Pioneer Natural Resources...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use ↗

May 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc...

Via Benzinga

The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More ↗

May 07, 2021

This was an eventful week for the cannabis industry. On Monday, Tilray, Inc. (NASDAQ:

Via Benzinga

Topics Cannabis

Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To Portfolio ↗

May 06, 2021

The biopharmaceutical company Jazz Pharmaceuticals, has finalized the acquisition of the cannabinoid drug company GW Pharmaceuticals plc.

Via Talk Markets

Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To Portfolio ↗

May 06, 2021

The biopharmaceutical company Jazz Pharmaceuticals (NASDAQ: JAZZ), has finalized the acquisition of the cannabinoid drug company GW Pharmaceuticals plc. (NASDAQ: GWPH). The...

Via Benzinga

Jazz Pharmaceuticals' Acquisition of GW Pharmaceuticals Closes ↗

May 05, 2021

The developer of cannabis-based medications is now under new ownership.

Via The Motley Fool

Jazz Pharmaceuticals PLC (JAZZ) Q1 2021 Earnings Call Transcript ↗

May 04, 2021

JAZZ earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Jazz Pharma Easily Beats Earnings Views, But Sales Come In Light ↗

May 04, 2021

Late Tuesday, Jazz Pharma reported adjusted earnings of $3.92 per share on $607.58 million in sales for its first quarter. Jazz stock was unmoved.

Via Investor's Business Daily

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.